Challenges for clinicians treating autoimmune pancreatitis:Current perspectives  

作　　者：Seong-Hun Kim Yun Chae Lee Hyung Ku Chon 

机构地区：[1]Division of Gastroenterology,Department of Internal Medicine,Jeonbuk National University Medical School,Jeonju 54907,South Korea [2]Department of Internal Medicine,Institution of Wonkwang Medical Science,Wonkwang University School of Medicine and Hospital,Iksan 54538,South Korea

出　　处：《World Journal of Clinical Cases》2023年第1期30-46,共17页世界临床病例杂志

摘　　要：Autoimmune pancreatitis(AIP)is a rare disease clinically characterized by obstructive jaundice,unintentional weight loss,acute pancreatitis,focal pancreatic mass,and diabetes.AIP is classified into two subtypes-type 1 and type 2-according to pathological findings,clinical features,and serology test results,but some cases may be defined as type not otherwise in the absence of pathological findings and inflammatory bowel disease.To address the differences in diagnostic criteria by country,standard diagnostic criteria for AIP were proposed in 2011 by an international consensus of expert opinions.Differential diagnosis of AIP from pancreatic ductal adenocarcinoma is important but remains challenging for clinicians.Fortunately,all subtypes of AIP show dramatic response to steroid treatment.This review discusses the current perspectives on the diagnosis and management of AIP in clinical practice.

关 键 词：Autoimmune pancreatitis Pancreatic cancer International consensus diagnostic criteria STEROID 

分 类 号：R576[医药卫生—消化系统]